Breast cancer patients were reflective of their differential expression of serum α1-antichymotrypsin (ACT), clusterin (CLU) and complement factor B (CFB) [7], while patients with nasopharyngeal carcinoma expressed the sole elevated levels of serum ceruloplasmin (CPL) [8]. This evidence concerns the gene CFB and breast cancer.